Liang You, MD, PhD
Professor
Surgery
School of Medicine

Education & Training

Show all (1) Hide

• Clinical Fellowship University of California, San Francisco

Grants and Projects

Show all (1) Hide

• The Role of Cul4A in Genome Stability and Cancer Development, NIH, 2010-2017

Publications (100)

Top publication keywords:
MesotheliomaAdaptor Proteins, Signal TransducingB7-H1 AntigenPleural NeoplasmsGene Expression Regulation, NeoplasticCarcinoma, Non-Small-Cell LungDown-RegulationCell Line, TumorLung NeoplasmsApoptosisPhosphoproteinsCasein Kinase IIHematoxylinTranscription FactorsCullin Proteins

• A novel isoform of Homeodomain-interacting protein kinase-2 promotes YAP/TEAD transcriptional activity in NSCLC cells.
  Oncotarget 2021 Dai Y, Kyoyama H, Yang YL, Wang Y, Liu S, Wang Y, Mao JH, Xu Z, Uematsu K, Jablons DM, You L
• The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC).
  Cancers 2020 Hsu PC, Yang CT, Jablons DM, You L
• Inhibition of cyclin-dependent kinase 7 down-regulates yes-associated protein expression in mesothelioma cells.
  Journal of cellular and molecular medicine 2019 Miao J, Kyoyama H, Liu L, Chan G, Wang Y, Urisman A, Yang YL, Liu S, Xu Z, Bin H, Li H, Jablons DM, You L
• Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
  International journal of molecular sciences 2019 Hsu PC, Jablons DM, Yang CT, You L
• The crystal structure of the protein kinase HIPK2 reveals a unique architecture of its CMGC-insert region.
  The Journal of biological chemistry 2019 Agnew C, Liu L, Liu S, Xu W, You L, Yeung W, Kannan N, Jablons D, Jura N

Show all (95 more) Hide

• Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model.
  Oncology reports 2019 Hsu PC, Tian B, Yang YL, Wang YC, Liu S, Urisman A, Yang CT, Xu Z, Jablons DM, You L
• Cul4A Modulates Invasion and Metastasis of Lung Cancer Through Regulation of ANXA10.
  Cancers 2019 Hung MS, Chen YC, Lin P, Li YC, Hsu CC, Lung JH, You L, Xu Z, Mao JH, Jablons DM, Yang CT
• The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer.
  Biomedicines 2018 Hsu PC, Yang CT, Jablons DM, You L
• Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma.
  Journal of cellular and molecular medicine 2018 Hsu PC, Miao J, Wang YC, Zhang WQ, Yang YL, Wang CW, Yang CT, Huang Z, You J, Xu Z, Jablons DM, You L
• Inhibition of yes-associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model.
  Journal of cellular and molecular medicine 2018 Hsu PC, Miao J, Huang Z, Yang YL, Xu Z, You J, Dai Y, Yeh CC, Chan G, Liu S, Urisman A, Yang CT, Jablons DM, You L
• YAP regulates PD-L1 expression in human NSCLC cells.
  Oncotarget 2017 Miao J, Hsu PC, Yang YL, Xu Z, Dai Y, Wang Y, Chan G, Huang Z, Hu B, Li H, Jablons DM, You L
• Hippo pathway in lung development.
  Journal of thoracic disease 2017 Dai Y, Jablons D, You L
• Drug development against the hippo pathway in mesothelioma.
  Translational lung cancer research 2017 Woodard GA, Yang YL, You L, Jablons DM
• DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma.
  International journal of oncology 2017 Wang H, Dai YY, Zhang WQ, Hsu PC, Yang YL, Wang YC, Chan G, Au A, Xu ZD, Jiang SJ, Wang W, Jablons DM, You L
• Targeting YAP in malignant pleural mesothelioma.
  Journal of cellular and molecular medicine 2017 Zhang WQ, Dai YY, Hsu PC, Wang H, Cheng L, Yang YL, Wang YC, Xu ZD, Liu S, Chan G, Hu B, Li H, Jablons DM, You L
• YAP1 regulates ABCG2 and cancer cell side population in human lung cancer cells.
  Oncotarget 2017 Dai Y, Liu S, Zhang WQ, Yang YL, Hang P, Wang H, Cheng L, Hsu PC, Wang YC, Xu Z, Jablons DM, You L
• YAP promotes erlotinib resistance in human non-small cell lung cancer cells.
  Oncotarget 2016 Hsu PC, You B, Yang YL, Zhang WQ, Wang YC, Xu Z, Dai Y, Liu S, Yang CT, Li H, Hu B, Jablons DM, You L
• Knockdown of cullin 4A inhibits growth and increases chemosensitivity in lung cancer cells.
  Journal of cellular and molecular medicine 2016 Hung MS, Chen IC, You L, Jablons DM, Li YC, Mao JH, Xu Z, Lung JH, Yang CT, Liu ST
• Knockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells.
  Oncology reports 2015 Hung MS, Chen IC, You L, Jablons DM, Li YC, Mao JH, Xu Z, Hsieh MJ, Lin YC, Yang CT, Liu ST, Tsai YH
• Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma.
  Journal of cellular and molecular medicine 2015 Yang YL, Ni J, Hsu PC, Mao JH, Hsieh D, Xu A, Chan G, Au A, Xu Z, Jablons DM, You L
• Analysis of lung tumor initiation and progression in transgenic mice for Cre-inducible overexpression of Cul4A gene.
  Thoracic cancer 2015 Wang Y, Xu Z, Mao JH, Hung MS, Hsieh D, Au A, Jablons DM, You L
• Genistein Suppresses Growth of Human Uterine Sarcoma Cell Lines via Multiple Mechanisms.
  Anticancer research 2015 Yeh CC, Fan Y, Jiang L, Yang YL, He B, You L, Mann M
• PR-Set7 is Degraded in a Conditional Cul4A Transgenic Mouse Model of Lung Cancer.
  Zhongguo fei ai za zhi = Chinese journal of lung cancer 2015 Wang Y, Xu Z, Mao JH, Hsieh D, Au A, Jablons DM, Li H, You L
• Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
  Oncotarget 2015 You B, Yang YL, Xu Z, Dai Y, Liu S, Mao JH, Tetsu O, Li H, Jablons DM, You L
• CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells.
  Journal of experimental & clinical cancer research : CR 2014 Zhang S, Yang YL, Wang Y, You B, Dai Y, Chan G, Hsieh D, Kim IJ, Fang LT, Au A, Stoppler HJ, Xu Z, Jablons DM, You L
• An alternative way to initiate Notch1 signaling in non-small cell lung cancer.
  Translational lung cancer research 2014 Yang YL, Jablons D, You L
• Lung tumourigenesis in a conditional Cul4A transgenic mouse model.
  The Journal of pathology 2014 Yang YL, Hung MS, Wang Y, Ni J, Mao JH, Hsieh D, Au A, Kumar A, Quigley D, Fang LT, Yeh CC, Xu Z, Jablons DM, You L
• CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression.
  Cancer research 2013 Wang Y, Wen M, Kwon Y, Xu Y, Liu Y, Zhang P, He X, Wang Q, Huang Y, Jen KY, LaBarge MA, You L, Kogan SC, Gray JW, Mao JH, Wei G
• Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model.
  International journal of oncology 2013 Hung MS, Xu Z, Chen Y, Smith E, Mao JH, Hsieh D, Lin YC, Yang CT, Jablons DM, You L
• Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.
  BMC pharmacology & toxicology 2013 Liu S, Hsieh D, Yang YL, Xu Z, Peto C, Jablons DM, You L
• Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer.
  BMC cancer 2013 Bravo DT, Yang YL, Kuchenbecker K, Hung MS, Xu Z, Jablons DM, You L
• Inhibition of CK2α down-regulates Notch1 signalling in lung cancer cells.
  Journal of cellular and molecular medicine 2013 Zhang S, Long H, Yang YL, Wang Y, Hsieh D, Li W, Au A, Stoppler HJ, Xu Z, Jablons DM, You L
• Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells.
  PloS one 2012 Zhang S, Wang Y, Mao JH, Hsieh D, Kim IJ, Hu LM, Xu Z, Long H, Jablons DM, You L
• The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesothelioma.
  Journal of clinical pathology 2012 Li T, Hou SC, Mao JH, Wang YC, Lu XD, Tan JL, You B, Liu YP, Ni J, Au A, Jablons DM, Xu Z, You L
• Transgenic mice for cre-inducible overexpression of the Cul4A gene.
  Genesis (New York, N.Y. : 2000) 2011 Li T, Hung MS, Wang Y, Mao JH, Tan JL, Jahan K, Roos H, Xu Z, Jablons DM, You L
• Cul4A is an oncogene in malignant pleural mesothelioma.
  Journal of cellular and molecular medicine 2011 Hung MS, Mao JH, Xu Z, Yang CT, Yu JS, Harvard C, Lin YC, Bravo DT, Jablons DM, You L
• The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma.
  The Journal of pathology 2011 Li T, Li H, Wang Y, Harvard C, Tan JL, Au A, Xu Z, Jablons DM, You L
• Adenovirus-mediated SOCS3 gene transfer inhibits the growth and enhances the radiosensitivity of human non-small cell lung cancer cells.
  Oncology reports 2010 Lin YC, Lin CK, Tsai YH, Weng HH, Li YC, You L, Chen JK, Jablons DM, Yang CT
• Functional polymorphism of the CK2alpha intronless gene plays oncogenic roles in lung cancer.
  PloS one 2010 Hung MS, Lin YC, Mao JH, Kim IJ, Xu Z, Yang CT, Jablons DM, You L
• Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of WIF-1 in lung cancer cells.
  Oncology reports 2009 Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong M, Zhi X, Jablons DM, You L
• Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
  Anticancer research 2009 Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong M, Zhi X, Jablon DM, You L
• Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library.
  BMC cancer 2009 Hung MS, Xu Z, Lin YC, Mao JH, Yang CT, Chang PJ, Jablons DM, You L
• Nasopharyngeal carcinoma--review of the molecular mechanisms of tumorigenesis.
  Head & neck 2008 Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM
• Evaluation of a chemical library of small-molecule Dishevelled antagonists that suppress tumor growth by down-regulating T-cell factor-mediated transcription.
  Molecular cancer therapeutics 2008 You L, Xu Z, Punchihewa C, Jablons DM, Fujii N
• Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus.
  Cancer science 2007 Clément G, Guilleret I, He B, Yagui-Beltrán A, Lin YC, You L, Xu Z, Shi Y, Okamoto J, Benhattar J, Jablons D
• Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth.
  Anticancer research 2007 Uematsu K, Seki N, Seto T, Isoe C, Tsukamoto H, Mikami I, You L, He B, Xu Z, Jablons DM, Eguchi K
• Inhibition of Wnt-2 and galectin-3 synergistically destabilizes beta-catenin and induces apoptosis in human colorectal cancer cells.
  International journal of cancer 2007 Shi Y, He B, Kuchenbecker KM, You L, Xu Z, Mikami I, Yagui-Beltran A, Clement G, Lin YC, Okamoto J, Bravo DT, Jablons DM
• Roles of secreted frizzled-related proteins in cancer.
  Acta pharmacologica Sinica 2007 Shi Y, He B, You L, Jablons DM
• Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth.
  Human gene therapy 2007 Lin YC, You L, Xu Z, He B, Yang CT, Chen JK, Mikami I, Clément G, Shi Y, Kuchenbecker K, Okamoto J, Kashani-Sabet M, Jablons DM
• Wnt inhibitory factor inhibits lung cancer cell growth.
  The Journal of thoracic and cardiovascular surgery 2007 Kim J, You L, Xu Z, Kuchenbecker K, Raz D, He B, Jablons D
• An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth.
  Cancer research 2007 Fujii N, You L, Xu Z, Uematsu K, Shan J, He B, Mikami I, Edmondson LR, Neale G, Zheng J, Guy RK, Jablons DM
• Stathmin is overexpressed in malignant mesothelioma.
  Anticancer research 2007 Kim JY, Harvard C, You L, Xu Z, Kuchenbecker K, Baehner R, Jablons D
• Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.
  Biochemical and biophysical research communications 2006 Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Clément G, Jablons DM
• Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.
  Biochemical and biophysical research communications 2006 Lin YC, You L, Xu Z, He B, Mikami I, Thung E, Chou J, Kuchenbecker K, Kim J, Raz D, Yang CT, Chen JK, Jablons DM
• Wnt-1 signal as a potential cancer therapeutic target.
  Drug news & perspectives 2006 You L, Kim J, He B, Xu Z, McCormick F, Jablons DM
• The role of Wnt signaling in cancer and stem cells.
  Future oncology (London, England) 2005 Reguart N, He B, Taron M, You L, Jablons DM, Rosell R
• Wnt2 as a new therapeutic target in malignant pleural mesothelioma.
  International journal of cancer 2005 Mazieres J, You L, He B, Xu Z, Twogood S, Lee AY, Reguart N, Batra S, Mikami I, Jablons DM
• Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis.
  Oncogene 2005 Mazieres J, You L, He B, Xu Z, Lee AY, Mikami I, McCormick F, Jablons DM
• Wnt signaling in stem cells and non-small-cell lung cancer.
  Clinical lung cancer 2005 He B, Barg RN, You L, Xu Z, Reguart N, Mikami I, Batra S, Rosell R, Jablons DM
• Efficacy of Wnt-1 monoclonal antibody in sarcoma cells.
  BMC cancer 2005 Mikami I, You L, He B, Xu Z, Batra S, Lee AY, Mazieres J, Reguart N, Uematsu K, Koizumi K, Jablons DM
• Wnt signaling in lung cancer.
  Cancer letters 2005 Mazieres J, He B, You L, Xu Z, Jablons DM
• Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.
  Oncogene 2005 He B, Reguart N, You L, Mazieres J, Xu Z, Lee AY, Mikami I, McCormick F, Jablons DM
• Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
  Cancer research 2005 He B, Lee AY, Dadfarmay S, You L, Xu Z, Reguart N, Mazieres J, Mikami I, McCormick F, Jablons DM
• Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma.
  Biochemical and biophysical research communications 2004 Lee AY, He B, You L, Xu Z, Mazieres J, Reguart N, Mikami I, Batra S, Jablons DM
• Cloning and characterization of the promoter of human Wnt inhibitory factor-1.
  Biochemical and biophysical research communications 2004 Reguart N, He B, Xu Z, You L, Lee AY, Mazieres J, Mikami I, Batra S, Rosell R, McCormick F, Jablons DM
• Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma.
  Oncogene 2004 Lee AY, He B, You L, Dadfarmay S, Xu Z, Mazieres J, Mikami I, McCormick F, Jablons DM
• Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.
  Oncogene 2004 You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, Reguart N, Moody TW, Kitajewski J, McCormick F, Jablons DM
• An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.
  Cancer research 2004 You L, He B, Xu Z, Uematsu K, Mazieres J, Fujii N, Mikami I, Reguart N, McIntosh JK, Kashani-Sabet M, McCormick F, Jablons DM
• Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts.
  The Annals of thoracic surgery 2004 Beseth BD, Cameron RB, Leland P, You L, Varricchio F, Kreitman RJ, Maki RA, Jablons DM, Husain SR, Puri RK
• Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer.
  Cancer research 2004 Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM
• Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells.
  Cancer research 2004 You L, He B, Uematsu K, Xu Z, Mazieres J, Lee A, McCormick F, Jablons DM
• Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer.
  Clinical lung cancer 2004 He B, You L, Xu Z, Mazieres J, Lee AY, Jablons DM
• A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells.
  Neoplasia (New York, N.Y.) 2004 He B, You L, Uematsu K, Xu Z, Lee AY, Matsangou M, McCormick F, Jablons DM
• Future directions: oncolytic viruses.
  Clinical lung cancer 2004 You L, He B, Xu Z, McCormick F, Jablons DM
• SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
  Proceedings of the National Academy of Sciences of the United States of America 2003 He B, You L, Uematsu K, Zang K, Xu Z, Lee AY, Costello JF, McCormick F, Jablons DM
• Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression.
  Oncogene 2003 Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM
• Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin.
  Cancer research 2003 Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, Peterlin BM, McCormick F, Jablons DM
• Genomic alterations in human mesothelioma including high resolution mapping of common regions of DNA loss in chromosome arm 6q.
  Anticancer research 2003 Jensen RH, Tiirikainen M, You L, Ginzinger D, He B, Uematsu K, Xu Z, Treseler P, McCormick F, Jablons DM
• Cloning and characterization of a functional promoter of the human SOCS-3 gene.
  Biochemical and biophysical research communications 2003 He B, You L, Uematsu K, Matsangou M, Xu Z, He M, McCormick F, Jablons DM
• A comparison analysis of anti-tumor efficacy of adenoviral gene replacement therapy (p14ARF and p16INK4A) in human mesothelioma cells.
  Anticancer research 2003 Yang CT, You L, Lin YC, Lin CL, Mccormick F, Jablons DM
• Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides.
  Molecular cancer therapeutics 2002 Xia C, Xu Z, Yuan X, Uematsu K, You L, Li K, Li L, McCormick F, Jablons DM
• p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.
  Cancer research 2001 Yang CT, You L, Uematsu K, Yeh CC, McCormick F, Jablons DM
• A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens.
  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001 Strickler HD, International SV40 Working Group
• Indomethacin reduces lung adenoma number in A/J mice.
  Anticancer research 2001 Moody TW, Leyton J, Zakowicz H, Hida T, Kang Y, Jakowlew S, You L, Ozbun L, Zia H, Youngberg J, Malkinson A
• Identification of differentially expressed nucleolar TGF-beta1 target (DENTT) in human lung cancer cells that is a new member of the TSPY/SET/NAP-1 superfamily.
  Genomics 2001 Ozbun LL, You L, Kiang S, Angdisen J, Martinez A, Jakowlew SB
• Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells.
  Lung cancer (Amsterdam, Netherlands) 2001 Casibang M, Purdom S, Jakowlew S, Neckers L, Zia F, Ben-Av P, Hla T, You L, Jablons DM, Moody TW
• Stage II (N1) lung cancer.
  Chest surgery clinics of North America 2001 Choy O, Jahan T, Roach M, You L, Jablons D
• Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells.
  Journal of the National Cancer Institute 2000 Yang CT, You L, Yeh CC, Chang JW, Zhang F, McCormick F, Jablons DM
• ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients.
  Cancer research 2000 You L, Yang CT, Jablons DM
• Transforming growth factor-beta expression in mouse lung carcinogenesis.
  Experimental lung research 1998 Jakowlew SB, Moody TW, You L, Mariano JM
• Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
  Molecular carcinogenesis 1998 Jakowlew SB, Moody TW, You L, Mariano JM
• Identification of early growth response gene-1 (Egr-1) as a phorbol myristate acetate-induced gene in lung cancer cells by differential mRNA display.
  American journal of respiratory cell and molecular biology 1997 You L, Jakowlew SB
• Differential regulation of protease and extracellular matrix protein expression by transforming growth factor-beta 1 in non-small cell lung cancer cells and normal human bronchial epithelial cells.
  Biochimica et biophysica acta 1997 Jakowlew SB, Mariano JM, You L, Mathias A
• Effects of transforming growth factor-beta 1 and phorbol ester on PAI-1 and PA genes in human lung cells.
  Growth factors (Chur, Switzerland) 1997 Jakowlew SB, Mariano JM, You L
• Carcinogenicity, DNA adduct formation and K-ras activation by 7H-dibenzo[c,g]carbazole in strain A/J mouse lung.
  Carcinogenesis 1996 Warshawsky D, Talaska G, Jaeger M, Collins T, Galati A, You L, Stoner G
• Frameshift mutation in codon 176 of the p53 gene in rat esophageal epithelial cells transformed by benzo[a]pyrene dihydrodiol.
  Molecular carcinogenesis 1995 Wang D, You L, Sneddon J, Cheng SJ, Jamasbi R, Stoner GD
• Tumor multiplicity, DNA adducts and K-ras mutation pattern of 5-methylchrysene in strain A/J mouse lung.
  Carcinogenesis 1994 You L, Wang D, Galati AJ, Ross JA, Mass MJ, Nelson GB, Wilson KH, Amin S, Stoner JC, Nesnow S
• Allele-specific activation and expression of the K-ras gene in hybrid mouse lung tumors induced by chemical carcinogens.
  Carcinogenesis 1994 Chen B, You L, Wang Y, Stoner GD, You M
• Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids.
  Proceedings of the National Academy of Sciences of the United States of America 1992 You M, Wang Y, Stoner G, You L, Maronpot R, Reynolds SH, Anderson M
• Activation of protooncogenes in mouse lung tumors.
  Experimental lung research 1991 You M, Wang Y, Lineen A, Stoner GD, You LA, Maronpot RR, Anderson MW